News Archive

2017

June

Media Release / Jun 15, 2017

Novartis’ secukinumab shows sustained improvements in signs and symptoms for both AS and PsA in up to 80% of patients at 3 years

Read More

May

Media Release / May 22, 2017

Novartis Philippines associates celebrate company’s 21st annual Community Partnership Day through volunteer activities

Read More

March

Featured News / Mar 28, 2017

Novartis gathers local experts, Filipino mothers to highlight women’s journey in ADHD, Alzheimer’s disease and epilepsy

Read More
Media Release / Mar 21, 2017

Novartis’ secukinumab is first and only IL-17A inhibitor to potentially modify the course of psoriasis

Read More
Media Release / Mar 20, 2017

Novartis partners with ADB, Swiss Embassy to hold forum on achieving universal health coverage in developing countries

Read More
Media Release / Mar 12, 2017

Novartis global survey shows 85% fear blindness, but only 33% have regular eye examination

Read More
Media Release / Mar 12, 2017

Novartis partners with Philippine Glaucoma Society to help prevent blindness, promote regular eye exams

Read More

February

Media Release / Feb 28, 2017

Novartis, Philippine Dermatological Society form partnership to provide continuing medical education on psoriasis diagnosis and management

Read More
Featured News / Feb 14, 2017

DOH, Novartis Foundation renew public-private partnership on leprosy control

Read More
2016

December

Media Release / Dec 09, 2016

Novartis’ ranibizumab receives EU approval in new indication – Ranibizumab the only treatment available for a wide range of CNV conditions

Read More

Pages